KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Shares Issued (2017 - 2025)

Guardant Health's Shares Issued history spans 9 years, with the latest figure at $251.1 million for Q4 2025.

  • For Q4 2025, Shares Issued rose 5470.93% year-over-year to $251.1 million; the TTM value through Dec 2025 reached $257.1 million, up 2094.11%, while the annual FY2025 figure was $257.1 million, 2094.11% up from the prior year.
  • Shares Issued for Q4 2025 was $251.1 million at Guardant Health, up from $3.7 million in the prior quarter.
  • Across five years, Shares Issued topped out at $492.8 million in Q4 2023 and bottomed at -$6.4 million in Q3 2023.
  • The 5-year median for Shares Issued is $1.2 million (2022), against an average of $44.8 million.
  • The largest annual shift saw Shares Issued crashed 196.9% in 2023 before it surged 5470.93% in 2025.
  • A 5-year view of Shares Issued shows it stood at -$5.4 million in 2021, then surged by 60.04% to -$2.2 million in 2022, then surged by 22937.16% to $492.8 million in 2023, then crashed by 99.09% to $4.5 million in 2024, then soared by 5470.93% to $251.1 million in 2025.
  • Per Business Quant, the three most recent readings for GH's Shares Issued are $251.1 million (Q4 2025), $3.7 million (Q3 2025), and $1.6 million (Q2 2025).